TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts

TrumpRx, the president's discount program for prescription drugs, is adding three more products to its site as it continues efforts to lower drug prices.

The newly added medicines include two for type 2 diabetes, Jentadueto and Jentadueto XR, and one for chronic obstructive pulmonary disease (COPD), Striverdi Respimat. 

All thre...

New Lyme Disease Vaccine Shows Strong Results in Trial

A new vaccine meant to prevent Lyme disease may be one step closer to approval.

Drugmaker Pfizer and French vaccine company Valneva said their vaccine, called LB6V, worked more than 70% of the time in a clinical trial to prevent Lyme disease in people ages 5 and older.

The companies also said the vaccine was well tolerated, with no s...

Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says

Cardinal Health is recalling some of its alcohol prep pads after tests found possible bacterial contamination that could lead to infections.

The company said certain lots of its Webcol Large Alcohol Prep Pads (70% isopropyl alcohol) may contain the bacteria Paenibacillus phoenicis.

These pads are commonly used to clean the s...

Study Warns Fluoride Bans May Raise Tooth Decay in Children

Removing fluoride from drinking water could lead to more cavities in kids and higher health care costs, a new analysis suggests.

Researchers estimate that if five states stop adding fluoride to public water, more than 132,000 additional kids could need dental treatment within three years. 

That includes procedures like fillings ...

Your Choice Of Booze Influences Your Risk Of Death, Study Says

Too much alcohol of any type is bad for a person’s health, but some booze is more harmful than others, a new study says.

Beer, cider and liquor all appear to increase people’s risk of an early death, even at low levels of imbibing, researchers are slated to report Saturday at a  meeting in New Orleans of the American Colle...

Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds

Biden-era policies have reined in insulin prices for Medicare patients, a new study says.

Roughly 3 out of 4 (75%) Medicare prescription beneficiaries were paying $35 or less for each month’s supply of insulin within a year of price caps enacted under President Joe Biden, researchers reported in the Journal of the American Medica...